1Hamik A, Oksenberg D, Fischette C; et al. Analysis of Tandospirone(SM-399) interactions with nearotansmitter receptor binding sites. Biol psychiatry, 1990,28:99-109.
2Yamada K, Yagi G, Kanba S. Clinical efficacy of Tandospirone augmentation in patients major depressive disorder: a randomized controlled trial. Psychiatry Clin Nearosci ,2003,57 ( 2 ) : 183-187.
3Yamauchi K, Yamada S, Morita K, et al. Comparative study of short-time anxiolytic potency of alprazolam and tandospirone in psychiatric outpatients with anxiety disorders. Hum Psychopharmacol, 2001,16 ( 6 ) :469 -73.
3Hans MaaswinkeI,Xi Le,Lucy He,et al.Dissociating the effects of habituation,black walls,buspirone and ethanol on anxiety-like behavioral responses in shoaling zebrafish. A 3 D approach to social behavior[J]. Pharmacology,Biochemistry and Behavior,2013,39(6):241-242.
